SKI Market

A+| A| A-|

Indian Indices

Sensex

73,583.22 -1,690.23
( -2.25%)

Global Indices

Nasdaq

45,202.56 -778.56
(-1.69%)

Dow Jones

6,394.42 -103.74
(-1.60%)

Hang Seng

53,412.46 -191.19
(-0.36%)

Nikkei 225

9,959.27 -12.90
(-0.13%)

Forex

USD-INR

94.09 0.23
(0.24%)

EUR-INR

108.64 -0.12
(-0.11%)

GBP-INR

125.57 -0.09
(-0.07%)

JPY-INR

0.59 0.00
(-0.07%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Lyka Labs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500259

INE933A01014

37.0210703

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LYKALABS

166.03

EPS(TTM)

Face Value()

Div & Yield %

Back

kapston services limited

Vaxtex Cotfab reports standalone net profit of Rs 3.95 crore in the December 2025 quarter

Feb 12,2026

Net profit of Vaxtex Cotfab reported to Rs 3.95 crore in the quarter ended December 2025 as against net loss of Rs 0.39 crore during the previous quarter ended December 2024. Sales reported to Rs 8.88 crore in the quarter ended December 2025. There were no Sales reported during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	8.88	0	0
OPM %	26.13	0	-
PBDT	3.86	-0.38	LP
PBT	3.86	-0.44	LP
NP	3.95	-0.39	LP

73,583.22 -1,690.23 ( -2.25%)

45,202.56 -778.56 (-1.69%)

6,394.42 -103.74 (-1.60%)

53,412.46 -191.19 (-0.36%)

9,959.27 -12.90 (-0.13%)

94.09 0.23 (0.24%)

108.64 -0.12 (-0.11%)

125.57 -0.09 (-0.07%)

0.59 0.00 (-0.07%)